top
Search terms
Results 1 - 10 of 10 - ordered by :
Ehjournal

Published Guidelines uniformly provide reninangiotensin system (RAS) inhibitors with a class IA recommendation for the treatment of patients with symptomatic heart failure (HF) due to systolic ...

European Heart Journal, Editorial, Kenneth Dickstein

Date : 07/09/2015
Ehjournal

Abstract Aims Although cardiac sympathetic activation is associated with adverse outcome in patients with chronic heart failure (CHF), the influence of renal sympathetic activity on outcome is ...

European Heart Journal, Petersson, Magnus, Friberg, Peter, Eisenhofer, Graeme, Lambert, Gavin, Rundqvist, Bengt

Date : 01/05/2005 Item size : 195172 bytes
Ehjournal

Renal dysfunction, as measured by the modification of diet in renal disease equations, and outcome in patients with advanced heart failure Abstract Aims This study evaluates the prognostic utility ...

European Heart Journal, Gardner, Roy S., Chong, Kwok S., O’Meara, Eileen, Jardine, Alan, Ford, Ian, McDonagh, Theresa A.

Date : 01/12/2007 Item size : 249661 bytes
Ehjournal

Renal impairment, worsening renal function, and outcome in patients with heart failure: an updated meta-analysis Abstract Aims Chronic kidney disease (CKD) and worsening renal function (WRF) have ...

European Heart Journal, Damman, Kevin, Valente, Mattia A.E., Voors, Adriaan A., O'Connor, Christopher M., van Veldhuisen, Dirk J., Hillege, Hans L.

Date : 14/02/2014 Item size : 603563 bytes
Ehjournal

Abstract Aims Although cardiac sympathetic activation is associated with adverse outcome in patients with chronic heart failure (CHF), the influence of renal sympathetic activity on outcome is ...

European Heart Journal, Petersson, Magnus, Friberg, Peter, Eisenhofer, Graeme, Lambert, Gavin, Rundqvist, Bengt

Date : 01/05/2005 Item size : 180169 bytes
Ehjournal

Published Guidelines uniformly provide reninangiotensin system (RAS) inhibitors with a class IA recommendation for the treatment of patients with symptomatic heart failure (HF) due to systolic ...

European Heart Journal, Dickstein, Kenneth

Date : 07/09/2015
Ehjournal

Methods and results Of the 4133 patients hospitalized with worsening HF and reduced left ventricular ejection fraction (LVEF) (40%) in the EVEREST trial, 2072 were randomized to tolvaptan, a ...

European Heart Journal, Blair, John E.A., Pang, Peter S., Schrier, Robert W., Metra, Marco, Traver, Brian, Cook, Thomas, Campia, Umberto, Ambrosy, Andrew, Burnett, John C., Grinfeld, Liliana, ...

Date : 01/10/2011 Item size : 327049 bytes
Ehjournal

Abstract Aims Although cardiac sympathetic activation is associated with adverse outcome in patients with chronic heart failure (CHF), the influence of renal sympathetic activity on outcome is ...

European Heart Journal, Petersson, Magnus, Friberg, Peter, Eisenhofer, Graeme, Lambert, Gavin, Rundqvist, Bengt

Date : 01/05/2005
Ehjournal

Renal impairment, worsening renal function, and outcome in patients with heart failure: an updated meta-analysis Abstract Aims Chronic kidney disease (CKD) and worsening renal function (WRF) have ...

European Heart Journal, Damman, Kevin, Valente, Mattia A.E., Voors, Adriaan A., O'Connor, Christopher M., van Veldhuisen, Dirk J., Hillege, Hans L.

Date : 14/02/2014 Item size : 602837 bytes
Ehjournal

Published Guidelines uniformly provide reninangiotensin system (RAS) inhibitors with a class IA recommendation for the treatment of patients with symptomatic heart failure (HF) due to systolic ...

European Heart Journal, Dickstein, Kenneth

Date : 07/09/2015 Item size : 148590 bytes